The UK's health secretary, Andrew Lansley, is accepting proposals for a new regulatory body that would speed up applications by scientists carrying out health research, and open up the UK — to a greater degree — to drug companies wanting to carry out clinical trials, reports The Guardian's Sarah Boseley.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.